8-K 1 stjude051675_8k.htm St. Jude Medical Form 8-K dated April 6, 2005

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):    April 6, 2005


ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)


Minnesota 0-8672 41-1276891
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

One Lillehei Plaza, St. Paul, MN 55117
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 8.01. Other Events.

On April 6, 2005, the Registrant issued a press release concerning the closing of the acquisition of the business of Velocimed LLC. A copy of which is furnished herewith as Exhibit 99.1.






Item 9.01. Financial Statements and Exhibits.

  (c)    Exhibits:

    99.1   Press release issued by the Company concerning the closing of the acquisition of the business of Velocimed LLC.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

           
    ST. JUDE MEDICAL, INC.


Dated:    April 7, 2005


By:  
 

/s/   Kevin T. O’Malley
 


Kevin T. O’Malley
Vice President and
General Counsel
 

EXHIBIT INDEX

Exhibit No. Description of Exhibit
 
99.1   Press Release dated April 7, 2005 announcing the closing of the acquisition of the business of Velocimed LLC